(Q28571827)

31 January 2017

title

COL1A1 oligodeoxynucleotides decoy: biochemical and morphologic effects in an acute wound repair model (English)

1 reference

31 January 2017

Shawn M. Rosensteel

1

1 reference

31 January 2017

Ronald P. Wilson

series ordinal

2

1 reference

31 January 2017

Sheryl L. White

series ordinal

3

1 reference

31 January 2017

H. Paul Ehrlich

series ordinal

4

1 reference

31 January 2017

publication date

1 December 2010

1 reference

Experimental and Molecular Pathology

31 January 2017

published in

1 reference

31 January 2017

volume

89

1 reference

31 January 2017

issue

3

1 reference

31 January 2017

page(s)

307–313

1 reference

E2F decoy oligodeoxynucleotides effectively inhibit growth of human tumor cells

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Wound contraction and fibrocontractive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

What is the prevalence of hypertrophic scarring following burns?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

A novel nonsteroidal antifibrotic oligo decoy containing the TGF-beta element found in the COL1A1 gene which regulates murine schistosomiasis liver fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

How is Type I procollagen synthesis regulated at the gene level during tissue fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Evidence for TGF-beta1 and bleomycin intracellular signaling through autocrine regulation of Smad 3 binding to the proximal promoter of the Smad 7 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

How do glucocorticoids compare to oligo decoys as inhibitors of collagen synthesis and potential toxicity of these therapeutics?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Anti-inflammatory prednisolone derivatives inhibit collagen synthesis and pro-alpha(1) (I) collagen promoter activity in rat skin fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

An algorithm for the release of burn contractures of the extremities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Transforming growth factor-beta1: its anti-inflammatory and pro-fibrotic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

c-Ski promotes skin fibroblast proliferation but decreases type I collagen: implications for wound healing and scar formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

How cells read TGF-beta signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Burn scars treated by pinhole method using a carbon dioxide laser

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

Polymerized collagen inhibits fibroblast proliferation via a mechanism involving the formation of a beta1 integrin-protein phosphatase 2A-tuberous sclerosis complex 2 complex that suppresses S6K1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2010.07.003

10.1016/J.YEXMP.2010.07.003

7 January 2021

Identifiers

DOI

1 reference

31 January 2017

1 reference